Language: Italiano

Gilead Sciences S.r.l

Via Melchiorre Gioia 26
20124 Milano
Italy

Phone: 39-02-439-201
Fax: 39-02-4802-2578

Medical Information

Email: itmedinfo@gilead.com

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

The Milan office has been in operation since 2000 and provides medical, sales and marketing support for Gilead’s products in Italy.

Transparency Reporting
In line with local Transparency Reporting requirements, Gilead is disclosing its interactions with HealthCare Professionals and HealthCare Organisations in Italy in the following report, supported by a Methodological Note. Enquiries about the report should be directed to: http://www.gilead.com/news/media-inquiries.

Gilead Sciences Italy EFPIA Report 2017
Gilead Sciences Italy EFPIA Methodological Note 2017 (In Italian)
Gilead Sciences Italy EFPIA Report 2016
Gilead Sciences Italy EFPIA Methodological Note 2016 (In Italian)
Gilead Sciences Italy EFPIA Report 2015
Gilead Sciences Italy EFPIA Methodological Note 2015 (In Italian)

Relationships with Charitable Organizations

Gilead provided support for the following charitable organizations in 2017, via unrestricted educational grants. The information is correct at the time of writing (March 2018). The information is subject to change and will be updated accordingly. For a listing of previous years' grants, click here.

  • Grant Recipient
    Description of Activity
    Amount Funded €
  • Fondazione Villa Maraini Onlus
    Community Award Program 2017
    25000
  • Istituto di Medicina Solidale Onlus
    Community Award Program 2017
    25000
  • Comunità San Patrignano Società Cooperativa Sociale
    Community Award Program 2017
    24000
  • Anlaids Onlus - Anlaids Lazio
    Community Award Program 2017
    25000
  • ArciLesbica Roma
    Community Award Program 2017
    20476
  • Arcobaleno Aids
    Community Award Program 2017
    20000
  • Associazione A.L.A. Milano Onlus
    Community Award Program 2017
    25000
  • RESET Società Cooperativa Sociale Impresa Sociale Onlus
    Community Award Program 2017
    25000
  • NPS Italia Onlus
    Community Award Program 2017
    25000
  • Asa-Associazione Solidarietà Aids Onlus
    Community Award Program 2017
    6500
  • Associazione "La Ricerca" Onlus
    Community Award Program 2017
    25000
  • Associazione "Terra Amica"
    Community Award Program 2017
    24950
  • Plus Onlus
    Community Award Program 2017
    25000
  • AIL Cosenza Fondazione Amelia Scorza ONLUS
    Community Award Program 2017
    25000
  • Fondazione LILA Milano Onlus - Lega Italiana per la Lotta contro l'AIDS
    Community Award Program 2017
    20000
  • ANLAIDS Sezione Lombardia
    Digital Health Program 2017
    40000
  • EPAC
    Osservatorio Permanente per L’Accesso al Farmaci Innovativi
    181100
  • NPS Italia Onlus
    Christmas Charities
    4000
  • Fondazione Banco Alimentare Onlus
    Christmas Charities
    5000
  • Associazione Ospedale dei Bambini Milano Buzzi Onlus
    Christmas Charities
    5000
  • Emergency - Life Support for Civilians War Victims
    Christmas Charities
    6000
  • Farsi Prossimo Onlus
    Christmas Charities
    6000
  • Istituto Pio XII Onlus
    Christmas Charities
    6000
  • Fondazione Opera San Francesco per i Poveri Onlus
    Christmas Charities
    5000
  • Associazione Peter Pan Onlus
    Christmas Charities
    3300
  • Dottor Sorriso Onlus
    Christmas Charities
    3300
  • L'altra Napoli - Associazione Napoletani Dentro
    Christmas Charities
    3300
  • SVR 24 (Società Cooperativa Sociale Onlus)
    Community Campaign (Congress)
    15000
  • Nadir Onlus
    Community Campaign (Magazines)
    80000
  • NPS Italia Onlus
    Community Campaign (Magazines)
    20000
Language: Italiano

*Indirect support to the association: granted amount not available.
This page is intended for visitors outside of the United States.